Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
deals
investing
2
×
life sciences
national blog main
national top stories
roche
san francisco blog main
san francisco top stories
2
×
amgen
avapritinib
blueprint medicines
boston
cancer
cancer drugs
cobimetinib
cstone pharmaceuticals
eli lilly
european medicines agency
fda
fisogatinib
flatiron health
genentech
hepatocellular carcinoma
ipo
jeff albers
medullary thyroid cancer
non-small cell lung cancer
pralsetinib
revolution medicines
san francisco
sanofi
selpercatinib
the column group
thermo fisher scientific
third rock ventures
thyroid cancer
What
cancer
drug
medicines
2
×
approval
blueprint
candidate
currently
despite
family
fda
hardest
hit
hottest
hunters
ipo
marketing
muscle
pact
proteins
ras
reels
regulatory
research
ret
review
revolution
roche
targets
team
wins
Language
unset
Current search:
investing
×
medicines
×
" san francisco top stories "
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer